EMERYVILLE, Calif., July 24, 2026--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and ...
EMERYVILLE, Calif., August 11, 2026--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and ...
LOS ANGELES--(BUSINESS WIRE)--Estrella Media, the transformative Spanish language media company serving a diverse multiplatform Latino audience in the U.S., and TV Azteca, one of the largest producers ...
LOS ANGELES--(BUSINESS WIRE)--Estrella Media, a leading multi-platform Spanish‑language media company serving the vital U.S. Hispanic audience, said it has become a growth leader in Spanish-language ...
It’s an old song, but it continues to ring true: U.S. Hispanics are underserved and oftentimes misunderstood. There are 62 million Hispanics in the U.S. with $2 trillion in purchasing power, and like ...
Forbes contributors publish independent expert analyses and insights. Veronica Villafañe is an expert in the Hispanic media industry. The Estrella TV network lags way behind powerhouses Univision and ...
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma Estrella Immunopharma, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results